🎉 Congratulations to today's "Daily Best" winners!
Each receives 50 USDT for their outstanding in-depth articles! 👏
📝 Today's winners & articles
@Mr_qiang777 https://www.gate.com/post/status/19028534
@Coinstages https://www.gate.com/zh/post/status/19031206
@PlayerYU https://www.gate.com/zh/post/status/19038966
🔥 The event is heating up — 3 winners are selected daily!
You could be tomorrow's pick! Share your market insights now and win 50 USDT plus official exposure!
👉 Join now: gate.com/post
#GateSquare #DeepCreationCamp #DailyBest
Why NeoGenomics (NEO) Shares Are Falling Today
Shares of NeoGenomics (NEO) fell over 10% after the oncology diagnostics company reported fourth-quarter results that beat expectations but issued a full-year 2026 forecast falling short of analyst predictions. Despite an 11% revenue growth in Q4 2025, the increased net loss for the full year 2025 and lower-than-anticipated 2026 guidance led to a negative market reaction. The company’s stock has been highly volatile, with significant drops in the past year, and is currently trading 22.6% below its 52-week high.